New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to stage 3 ...

Ovacome, the UK’s ovarian cancer support charity, will host two events in Wales this August. 7,500 people are diagnosed with ...

Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to stage 3 ...

More information: Chenxiang Pan, BM et al.Construction of a nomogram prediction model for deep vein thrombosis in epithelial ovarian cancer, Menopause (2025). DOI: 10.1097/GME.0000000000000002603 ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...

For more information about ovarian cancer, the risk factors, symptoms and treatments, and the resources available locally, visit H.O.W.’s website. Find more ways to stay up to date with your ...

National Institute of Health and Care Excellence (NICE) representatives believe it vital not to spread misinformation about ...

If you're concerned about breast cancer affecting you or someone close to you, this article can help you learn more about: ...